The Institute for Protein Design is proud to announce that our Executive Director, Lynda Stuart, has been appointed to the Scientific Advisory Committee (SAC) of the Coalition for Epidemic Preparedness Innovations (CEPI).
CEPI, a key player in global health initiatives, has expanded its SAC with nine new experts, including Lynda, to steer its innovative endeavors in vaccine development and outbreak response. This esteemed group provides technical guidance on R&D programs, shaping the strategies to confront emerging infectious diseases and future epidemic and pandemic threats.
Lynda’s appointment comes at a crucial time as CEPI responds to the evolving vaccine development landscape, striving to integrate recent progress in structural vaccinology and mRNA technology and explore new regulatory strategies. Her expertise aligns with the coalition’s commitment to scientific excellence and the ambitious ‘100 Days Mission‘ to expedite vaccine development against novel pathogens.
The SAC, an independent entity within CEPI, collaborates closely with the organization to ensure the effective implementation of strategic objectives, drawing on the diverse experiences and insights of its members.
Since its founding in 2017, CEPI’s mission has been to accelerate vaccine development, aiming to make them accessible to all, a vision that Lynda will further with her unique scientific and R&D expertise.